Systemische Immuntherapie und lokale Anwendung von Imiquimod als postoperative Rezidivprophylaxe bei Condylomata acuminata gigantea (Buschke-Löwenstein)

2004 ◽  
Vol 30 (10) ◽  
Author(s):  
S Steinhäuser ◽  
A Wagner ◽  
W Tilgen ◽  
D Dill-Müller
Urology ◽  
2005 ◽  
Vol 65 (2) ◽  
pp. 247-250 ◽  
Author(s):  
Bahgat Metawea ◽  
Abdel-Rahman El-Nashar ◽  
Ihab Kamel ◽  
Wafaa Kassem ◽  
Rany Shamloul

2010 ◽  
Vol 03 (04) ◽  
Author(s):  
Sachit Sharma ◽  
Shilpa Sharma ◽  
Santosh K Singh ◽  
Devendra S Pawar ◽  
Atul Khandelwal

2021 ◽  
Vol 19 (3) ◽  
pp. 454-456
Author(s):  
Furong Li ◽  
Yuexin Zhang ◽  
Qianxi Li ◽  
Hang Li ◽  
Xuejun Zhu ◽  
...  

1993 ◽  
Vol 4 (3) ◽  
pp. 159-164 ◽  
Author(s):  
A J Borg ◽  
G Medley ◽  
S M Garland

A total of 377 women, consecutively selected as first attenders to a sexually transmitted diseases clinic in Melbourne, Australia, were examined for overt Condylomata acuminata and were screened for genital HPV DNA types 6, 11, 16, 18, 31, 33 and (35) using 2 dot blot hybridization methods. Overall, there was a 90% positivity correlation between the 2 methods with HPV DNA being detected in 12% of ectocervical samples. Overt warts were found in 15% of the women and HPV DNA was detected at the cervix in 35% with cytology predicting HPV with or without dysplasia in 27%. Thirteen percent had a past history of warts but none on examination and HPV DNA was evident in 16% while 18% had cytological features of HPV. Those with no warts evident and no past history of warts had both HPV DNA and cytological features of HPV in 7%.


Sign in / Sign up

Export Citation Format

Share Document